Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review

Guy's and St Thomas' NHS Foundation Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Guy's and St Thomas' NHS Foundation Trust (Guy's and St Thomas'), a subsidiary of NHS England, is a major healthcare provider in the UK. It provides a range of general and specialist hospital services and community health services. Its major services include intensive care, emergency care, cancer treatment, cardiovascular and respiratory care, and transplant programs. The trust offers integrated acute and community healthcare services. Guy's and St Thomas' also include Evelina London Children’s Hospital. It serves local communities in Lambeth and Southwark and offers specialist care to patients from broader regions. It collaborates with academic and healthcare partners such as King’s Health Partners and Imperial Healthcare Partners. The Trust operates across multiple locations in south London, including Guy’s, St Thomas’, Royal Brompton, and Harefield hospitals. Guy’s and St Thomas’ is headquartered in London, the UK.

Guy's and St Thomas' NHS Foundation Trust Key Recent Developments

Jul 15,2024: Dr Claire Shannon elected Royal College of Anaesthetists President
Mar 28,2024: Guy's and St Thomas' NHS Foundation Trust Appoints New Chief People Officer

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note:Some sections may be missing if data is unavailable for the company.


Section 1 - About the Company
Navamedic ASA - Key Facts
Navamedic ASA - Key Employees
Navamedic ASA - Key Employee Biographies
Navamedic ASA - Major Products and Services
Navamedic ASA - History
Navamedic ASA - Company Statement
Navamedic ASA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Navamedic ASA - Business Description
Product Category: Consumer Health
Performance
Product Category: Hospital
Performance
Product Category: Precription Drugs (Rx)
Performance
Geographical Segment: Denmark
Performance
Geographical Segment: Finland
Performance
Geographical Segment: Norway
Performance
Geographical Segment: Other countries
Performance
Geographical Segment: Sweden
Performance
Geographical Segment: The Netherlands
Performance
Navamedic ASA - Corporate Strategy
Navamedic ASA - SWOT Analysis
SWOT Analysis - Overview
Navamedic ASA - Strengths
Navamedic ASA - Weaknesses
Navamedic ASA - Opportunities
Navamedic ASA - Threats
Navamedic ASA - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
Navamedic ASA, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 12, 2025: Navamedic Q4 and Full Year 2024: Continued Growth in a Year with Investments in New Growth Initiatives
Oct 31, 2024: Navamedic Q3 2024: Business Remains Strong in Quarter Impacted by Cyclical Nature of the Business
Oct 07, 2024: Navamedic Wins Joint Nordic Antibiotics Tender
May 16, 2024: Navamedic : Renewed Contract for Delivering Antibiotics to Norwegian Hospitals
Apr 30, 2024: Navamedic Q1 2024: Successful product launch and steady operational progress
Apr 23, 2024: Navamedic Announce Invitation for First Quarter 2024
Feb 15, 2024: Navamedic Announces Q4 and Full Year 2023
Feb 15, 2024: Navamedic Q4 and Full Year 2023: A Year Marked by New Records and Transformative Growth Initiatives
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Navamedic ASA, Key Facts
Navamedic ASA, Key Employees
Navamedic ASA, Key Employee Biographies
Navamedic ASA, Major Products and Services
Navamedic ASA, History
Navamedic ASA, Other Locations
Navamedic ASA, Subsidiaries
Navamedic ASA, Key Competitors
Navamedic ASA, Ratios based on current share price
Navamedic ASA, Annual Ratios
Navamedic ASA, Annual Ratios (Cont...1)
Navamedic ASA, Annual Ratios (Cont...2)
Navamedic ASA, Interim Ratios
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
Navamedic ASA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Navamedic ASA, Performance Chart (2020 - 2024)
Navamedic ASA, Ratio Charts
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings